Investigating the clinical aspects of using CT vs. CT-MRI images during organ delineation and treatment planning in prostate cancer radiotherapy

Technology in Cancer Research and Treatment

Volumn 10, Issue 3, 2011, Pages 231-242

  Tzikas, A ^a   Karaiskos, P ^b,c   Papanikolaou, N ^d   Sandilos, P ^b,e   Koutsouveli, E ^b   Lavdas, E ^f   Scarleas, C ^b   Dardoufas, K ^b,e   Lind, B K ^a   Mavroidis, P ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b HYGEIA HOSPITAL   (Greece)

^c UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^d UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^e UNIVERSITY OF ATHENS   (Greece)

^f UNIVERSITY HOSPITAL OF LARISSA   (Greece)

Author keywords

CT MRI images; Organ delineation; Prostate cancer radiotherapy; Radiobiological measures

Indexed keywords

ALGORITHM; ARTICLE; BLADDER; CANCER CONTROL; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL FEATURE; COMPARATIVE STUDY; COMPUTER ASSISTED RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DOSIMETRY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PROSTATE CANCER; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RECTUM; TREATMENT PLANNING;

EID: 79955529262     PISSN: 15330346     EISSN: None     Source Type: Journal    
DOI: 10.7785/tcrt.2012.500198     Document Type: Article

References (33)

1. Chen, L., Price, R. A. Jr., Wang, L., Li, J., Qin, L., McNeeley, S., Ma, C. M., Freedman, G. M., Pollack, A. MRI-based treatment planning for radiotherapy: dosimetric verification for prostate IMRT. Int J Radiat Oncol Biol Phys 60, 636-647 (2004).
2. Jackson, A. S., Reinsberg, S. A., Sohaib, S. A., Charles-Edwards, E. M., Mangar, S. A., South, C. P., Leach, M.O., Dearnaley, D.P. Distortion-corrected T2 weighted MRI: a novel approach to prostate radiotherapy planning. Br J Radiol 80, 926-933 (2007).
3. Villeirs, G. M., De Meerleer, G. O. Magnetic resonance imaging (MRI) anatomy of the prostate and application of MRI in radiotherapy planning. Eur J Radiol 63, 361-368 (2007).
4. Rørvik, J., Halvorsen, O. J., Espeland, A., Haukaas, S. Inability of CT to assess local extent of prostate. Acta Radiol 34, 39-42 (1993).
5. Nunes, L. W., Schiebler, M. S., Rauschning, W., Schnall, M. D., Tomaszewski, J. E., Pollack, H., Kressel, H. The normal prostate and periprostatic structures: correlation between MR images made with an endorectal coil and cadaveric microtome sections. AJR Am J Roentgenol 164, 923-927 (1995).
6. Villeirs, G. M., Van Vaerenbergh, K., Vakaet, L., Bral, S., Claus, F., De Neve, W. J., Verstraete, K. L., De Meerleer, G. O. Interobserver delineation variation using CT versus combined CT+MRI in intensity-modulated radiotherapy for prostate cancer. Strahlenther Onkol 181, 424-430 (2005).
7. Rasch, C., Barillot, I., Remeijer, P., Touw, A., van Herk, M., Lebesque, J. V. Definition of the prostate in CT and MRI: a multi-observer study. Int J Radiat Oncol Biol Phys 43, 57-66 (1999).
8. Debois, M., Oyen, R., Maes, F., Verswijvel, G., Gatti, G., Bosmans, H., Feron, M., Bellon, E., Kutcher, G., Van Poppel, H., Vanuytsel, L. The contribution of magnetic resonance imaging to the three-dimensional treatment planning of localized prostate cancer. Int J Radiat Oncol Biol Phys 45, 857-865 (1999).
9. Steenbakkers, R. J., Deurloo, K. E., Nowak, P. J., Lebesque, J. V., van Herk, M., Rasch, C. R. Reduction of dose delivered to the rectum and bulb of the penis using MRI delineation for radiotherapy of the prostate. Int J Radiat Oncol Biol Phys 57, 1269-1279 (2003).
10. ICRU Report No. 62. Prescribing, recording and reporting photon beam therapy (A supplement to ICRU Report No. 50). International Commission on Radiation Units and Measurements, 1-52 (1999).
11. Mavroidis, P., Lind, B. K., Van Dijk, J., Koedooder, K., De Neve, W., De Wagter, C., Planskoy, B., Rosenwald, J. C., Proimos, B., Kappas, C., Danciu, C., Benassi, M., Chierego, G., Brahme, A. Comparison of conformal radiation therapy techniques within the dynamic radiotherapy project 'DYNARAD'. Phys Med Biol 45, 2459-2481 (2000).
12. Mavroidis, P., Lind, B. K., Brahme, A. Biologically effective uniform dose (D) for specification, report and comparison of dose response relations and treatment plans. Phys Med Biol 46, 2607-2630 (2001).
13. Källman, P., Lind, B. K., Brahme, A. An algorithm for maximizing the probability of complication free tumor control in radiation therapy. Phys Med Biol 37, 871-890 (1992).
14. Emami, B., Lyman, J., Brown, A., Coia, L., Goitein, M., Munzenrider, J. E., Shank, B., Solin, L. J., Wesson, A. M. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 21, 109-22 (1991).
15. Brahme, A. Which parameters of the dose distribution are best related to the radiation response of tumours and normal tissues. In Proceedings of the Interregional Seminars for Europe, the Middle East and Africa Organized by the IAEA, Leuven, 37-58 (1994).
16. Ågren, A. K. Quantification of the response of heterogeneous tumors and organized normal tissues to fractionated radiotherapy. PhD Thesis. Stockholm University (1995).
17. Ågren, A.-K., Brahme, A., Turesson, I. Optimization of uncompli cated control for head and neck tumors. Int J Radiat Oncol Biol Phys 19, 1077-1085 (1990).
18. Källman, P., Ågren, A. K., Brahme, A. Tumor and normal tissue responses to fractionated non uniform dose delivery. Int J Radiat Biol 62, 249-262 (1992).
19. Jackson, A., Ten Haken, R. K., Robertson, J. M., Kessler, M. L., Kutcher, G. J., Lawrence, T. S. Analysis of clinical complication data for radiation hepatitis using a parallel architecture model. Int J Radiat Oncol Biol Phys 31, 883-891 (1995).
20. Lind, B. K., Mavroidis, P., Hyödynmaa, S., Kappas, C. Optimization of the dose level for a given treatment plan to maximize the complication free tumor cure. Acta Oncol 38, 787-798 (1999).
21. Mavroidis, P., Laurell, G., Kraepelien, T., Fernberg, J. O., Lind, B. K., Brahme, A. Determination and clinical verification of dose-response parameters for esophageal stricture from head and neck radiotherapy. Acta Oncol 42, 865-881 (2003).
22. Mavroidis, P., al-Abany, M., Helgason, A. R., Ågren Cronqvist, A. K., Wersäll, P., Theodorou, K., Kappas, C., Lind, H., Lind, B. K., Steineck, G., Brahme, A. Dose-response relations for anal sphincter regarding faecal leakage and blood or phlegm in stools after radiotherapy for prostate cancer. Strahlenter Onkol 181, 293-306 (2005).
23. De Meerleer, G., Vakaet, L., De Gersem, W., Villeirs, G., De Neve, W. Direct segment aperture and weight optimization for Intensity-Modulated radiotherapy of prostate cancer. Strahlenther Onkol 180, 136-143 (2004).
24. Brahme, A. The need for accurate target and dose specifications in conventional and conformal radiation therapy - An introduction. Acta Oncol 36, 789-792 (1997).
25. Kölbl, O., Richter, S., Flentje, M. Influence of treatment technique on dose-volume histogram and normal tissue complication probability for small bowel and bladder. Strahlenther Onkol 176, 105-111 (2000).
26. Parker, C. C., Damyanovich, A., Haycocks, T., Haider, M., Bayley, A., Catton, C. N. Magnetic resonance imaging in the radiation treatment planning of localized prostate cancer using intra-prostatic fiducial markers for computed tomography co-registration. Radiother Oncol 66, 217-224 (2003).
27. Rosewall, T., Kong, V., Vesprini, D., Catton, C., Chung, P., Ménard, C., Bayley, A. Prostate delineation using CT and MRI for radiotherapy patients with bilateral hip prostheses. Radiother Oncol 90, 325-330 (2009).
28. Ferreira, B. C., Svensson, R., Löf, J., Brahme, A. The clinical value of non-coplanar photon beams in biologically optimized intensity modulated dose delivery on deep seated tumors. Acta Oncol 42, 852-864 (2003).
29. Claus, F. G., Hricak, H., Hattery, R.R. Pretreatment Evaluation of Prostate Cancer: Role of MR Imaging and 1H MR Spectroscopy. Radiograph 24, S167-S180 (2004).
30. Hou, A. H., Swanson, D., Barqawi, A. B. Modalities for imaging of prostate cancer. Adv Urol 818065 (2009).
31. Weinreb, J. C., Blume, J. D., Coakley, F. V., Wheeler, T. M., Cormack, J. B., Sotto, C. K., Cho, H., Kawashima, A., Tempany-Afdhal, C. M., Macura, K. J., Rosen, M., Gerst, S. R., Kurhanewicz, J. Prostate cancer: sextant localization at MR imaging and MR spectroscopic imaging before prostatectomy-results of ACRIN prospective multi-institutional clinicopathologic study. Radiology 251, 122-133 (2009).
32. Scheidler, J., Hricak, H., Vigneron, D. B., Yu, K. K., Sokolov, D. L., Huang, L. R., Zaloudek, C. J., Nelson, S. J., Carroll, P. R., Kurhanewicz, J. Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging clinicopathologic study. Radiology 213, 473-480 (1999).
33. Beasley, M., Driver, D., Dobbs, H. J. Complications of radiotherapy: improving the therapeutic index. Cancer Imag 5, 78-84 (2005).